GEP-NET
Clinical trials for GEP-NET explained in plain language.
Never miss a new study
Get alerted when new GEP-NET trials appear
Sign up with your email to follow new studies for GEP-NET, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation drug trial offers hope for Tough-to-Treat gut cancers
Disease control Recruiting nowThis study is testing whether a new radioactive drug called RYZ101 works better than standard treatments for advanced neuroendocrine tumors of the gut and pancreas. It's for people whose tumors have grown despite previous radiation therapy. The trial will measure how long the dru…
Matched conditions: GEP-NET
Phase: PHASE3 • Sponsor: RayzeBio, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Looking back to predict the future: unlocking clues in neuroendocrine cancer treatment
Knowledge-focused Recruiting nowThis study aims to understand why some patients with neuroendocrine tumors of the gut and pancreas respond better to certain medications than others. Researchers will look back at the medical records of 450 patients who were treated with standard drugs to see if factors like age,…
Matched conditions: GEP-NET
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Apr 04, 2026 00:21 UTC